Interestingly the disialoganglioside GD2 and B7-H3 may represent potential therapeutic targets in these tumors:Retinoblastoma, like neuroblastoma cells express GD2 on their surface [6, 7]. This evidence concerns the gene CD276 and retinoblastoma.